Upstream Biotechnology, Inc. specializes in developing natural RNA-based solutions to enhance plant resilience against diseases.
Subscribe to see Upstream Biotechnology’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Upstream Biotechnology is a biotechnology company headquartered in United States. It has raised at least $625,000 across the 3 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round closed in July 2026. Xcout tracks 18 named people at Upstream Biotechnology, including George H. Greene (Chief Executive Officer).
12 more named people on record for Upstream Biotechnology, with roles, board committees and tenure — see the full roster →
At least $625,000 raised across the 3 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 13 named | |
| Series A | Undisclosed | 13 named | |
| SEC Form D filing | $625,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.